News
For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist ...
For patients with Parkinson's disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist ...
4d
Zacks Investment Research on MSNAMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease IndicationAmgen AMGN announced that the FDA has approved its rare disease drug Uplizna (inebilizumab) for a new indication. The ...
The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results